Kangmei Pharmaceutical Co Ltd. Stock Analysis 600518.SS

Kangmei Pharmaceutical Co., Ltd. engages in the trade, production, and sales of Chinese herbal medicine pieces, patent medicine preparations, health foods, chemicals and medical devices, modern pharmaceutical logistics system. The company is headquartered in Shenzhen, Guangdong and currently employs 5,492 full-time employees. The company went IPO on 2001-03-19. The firm's main products include Chinese herbal medicines, Chinese patent medicines, chemical medicines, health foods and foods. Chinese herbal medicines include Panax notoginseng powder, American ginseng, Kangmei lily, Kangmei salvia miltiorrhiza, and others. The main chemical medicine products are acetaminophen powder and norfloxacin capsules. The main foods are chrysanthemum tea, solid beverages, ginseng tablets, and red ginseng extract. The firm is also engaged in medical equipment, property leasing and sales and other services. The firm mainly conducts business in the domestic market.